| ²é¿´: 883 | »Ø¸´: 3 | |||
zlwcwľ³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
°ÙʱÃÀÊ©¹ó±¦¹«Ë¾ÓëÇ廪´óѧ´ï³ÉеÄÕ½ÂÔºÏ×÷»ï°é¹ØÏµ ÒÑÓÐ3È˲ÎÓë
|
|
Bristol-Myers Squibb has entered into a new multi-year strategic partnership with the Tsinghua University of Beijing. The pharmaceutical company will be funding research efforts at the Chinese university's school of life sciences, focusing on the identification of novel targets in oncology and immunoscience. In addition, the partnership will focus on structural biology research, a process involving mapping the 3D protein structure of biological molecular targets to serve as the basis for future drug discovery projects. This will be the first time that Bristol-Myers Squibb has entered into a China-based discovery collaboration, with the resulting research to benefit patients around the world. Dr Francis Cuss, senior vice-president for research at Bristol-Myers Squibb, said: "We are delighted to be working with Tsinghua University, a world-renowned and highly esteemed research-based academic institution with expertise in target identification and structural biology that will support the discovery of new medicines." Earlier this year, the firm announced a new alliance with the Duke Translational Medicine Institute, which will initially focus on the development of an idiopathic pulmonary fibrosis drug. 2012Äê5ÔÂ16ÈÕ£¬°ÙʱÃÀÊ©¹ó±¦£¨Bristol-Myers Squibb£©¹«Ë¾ÒÑÓëÇ廪´óѧ´ï³ÉÕ½ÂÔºÏ×÷»ï°é¹ØÏµ¡£ °ÙʱÃÀÊ©¹ó±¦¹«Ë¾½«×ÊÖúÇ廪´óѧÉúÃü¿ÆÑ§Ñ§ÔºµÄÑо¿¹¤×÷£¬ÖصãÔÚÓÚÖ×Áöѧ¼°ÃâÒßѧÁìÓòабêµÄ¼ø¶¨¡£´ËÍ⣬´Ë´ÎºÏ×÷¹ØÏµ½«Öصã·ÅÔڽṹÉúÎïѧÑо¿¡£½á¹¹ÉúÎïÑ§Éæ¼°Ãè»æÉúÎï·Ö×ӰбêµÄ3Dµ°°×½á¹¹£¬ÎªÎ´À´µÄÒ©Î↑·¢ÏîÄ¿µì¶¨»ù´¡¡£ ÕâÊÇÊ©¹ó±¦¹«Ë¾Ê×´ÎÓëÎÒ¹úµÄ¿ÆÑлú¹¹´ï³ÉºÏ×÷»ï°é£¬¸ÃÏîÑо¿ºÏ×÷µÄ½á¹û½«Ô츣ÊÀ½ç¸÷µØµÄ»¼Õß¡£ Ê©¹ó±¦¹«Ë¾Ñз¢¸ß¼¶¸±×ܲÃFrancis Cuss²©Ê¿³Æ£º"ÎÒÃǺܸßÐËÄÜÓëÇ廪´óѧչ¿ªºÏ×÷¡£Ç廪´óѧÊÇÏíÓþÈ«Çò¼°±¸ÊÜ×ð¾´µÄרҵѧÊõ»ú¹¹£¬ÆäÔڰбêʶ±ð¼°½á¹¹ÉúÎïѧ·½ÃæµÄרҵ֪ʶ½«ÓÐÖúÓÚÐÂÒ©ÎïµÄ̽Ë÷ºÍ·¢ÏÖ¡£" ½ñÄêÔçЩʱÆÚ£¬Ê©¹ó±¦¹«Ë¾Ðû²¼Óë¶Å¿Ë´óѧת»¯Ò½Ñ§Ñо¿Ëù´ï³ÉеÄÁªÃË£¬ºÏ×÷×î³õ½«×¨×¢ÓÚÌØ·¢ÐÔ·ÎÏËά»¯Ò©ÎïµÄ¿ª·¢¡££¨ÉúÎï¹Èbioon.com£© |
» ²ÂÄãϲ»¶
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ3È˻ظ´
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ238È˻ظ´
ÉúÎï×éÖ¯ÖÐÓÐÄ¿±ê·ÖÎöÎרÊôÐÔÔõô×ö
ÒѾÓÐ0È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
Ò©Îï¼ì²âÖÐ΢ÉúÎïÏ޶ȼÆÊý½á¹ûÅжÏ
ÒѾÓÐ0È˻ظ´
É격×Ô¼ö
ÒѾÓÐ2È˻ظ´
Çë½Ìִҵҩʦ±¨¿¼µÄһЩÎÊÌâ
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Ç廪´óѧºìÍâ¹âÆ×
ÒѾÓÐ325È˻ظ´
Ïò´ó¼Ò½éÉܲÄÁÏÀàÐÂÔÓÖ¾£¨J Adv Ceramics£¬Ç廪´óѧÖ÷°ì£©
ÒѾÓÐ13È˻ظ´
¹úÁ¢Ç廪´óѧ2012ÄêÔÚElectrochimica ActaÉϹØÓÚLiNi0.5Mn1.5O4µÄÎÄÕÂ
ÒѾÓÐ52È˻ظ´
ÓÐÄÄλͬѧ֪µÀÇ廪´óѧÄâ¼ȡÃûµ¥Ê²Ã´Ê±ºò³öÀ´Âð
ÒѾÓÐ15È˻ظ´
Ç廪´óѧˮÀûϵ²©Ê¿ºóÕÐÆ¸£¨×ª·¢£©
ÒѾÓÐ5È˻ظ´
¹ØÓÚ°Ä´óÀûÑǵĿÉÀûÓúÏ×÷ÏîÄ¿--½ô¼±ÇóÖú
ÒѾÓÐ5È˻ظ´
ÕÐÆ¸²©Ê¿ºó Ç廪´óѧµØÇòϵͳÑо¿ÖÐÐÄÈ«ÇòÉú̬ѧÑо¿×é
ÒѾÓÐ4È˻ظ´
Ç廪´óѧ²ÄÁÏϵÅËΰ½ÌÊÚ¿ÎÌâ×éÕÐÆ¸ÊµÑéÊÒ¹ÜÀíÈËÔ±1Ãû
ÒѾÓÐ27È˻ظ´
Ç廪´óѧÖܼýÌÊÚ¿ÎÌâ×鲩ʿºóÕÐÆ¸ÆôÊÂ
ÒѾÓÐ14È˻ظ´
¡¾Ô´´¡¿Ç廪´óѧÒÑ¿ªÊ¼·¢·Åµ÷µµº¯ÁË£¬Çë´ó¼Ò×¢Òâ²éÊÕÓʼþ֪ͨ
ÒѾÓÐ19È˻ظ´
aj412
¾èÖú¹ó±ö (ÖøÃûдÊÖ)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 18.5
- É¢½ð: 10
- ºì»¨: 1
- Ìû×Ó: 1224
- ÔÚÏß: 487.2Сʱ
- ³æºÅ: 89383
- ×¢²á: 2005-08-28
- רҵ: ºÏ³ÉÒ©Îﻯѧ
2Â¥2012-05-17 11:51:12
h_chen
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 33 (СѧÉú)
- ½ð±Ò: 6522.1
- É¢½ð: 675
- ºì»¨: 10
- Ìû×Ó: 1898
- ÔÚÏß: 182Сʱ
- ³æºÅ: 1088109
- ×¢²á: 2010-09-03
- ÐÔ±ð: GG
- רҵ: ÌìÈ»Óлú»¯Ñ§

3Â¥2012-05-17 13:35:49
1994yw
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 1708.3
- É¢½ð: 105
- Ìû×Ó: 646
- ÔÚÏß: 79.5Сʱ
- ³æºÅ: 1242523
- ×¢²á: 2011-03-23
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
4Â¥2012-05-17 13:53:20









»Ø¸´´ËÂ¥

20